一二三四区视频,亚洲少妇熟女色,日本久热无码视频网,欧美国产日韩大尺度,亚洲a视频,久久少妇一区二区,日韩999无码视频,刺激久久久久久久,啊啊啊啊不要啊在线

ChemicalBook >> journal list >> Drug Resistance Updates >>article
Drug Resistance Updates

Drug Resistance Updates

IF: 15.8
Download PDF

CPSF6-mediated XBP1 3’UTR shortening attenuates cisplatin-induced ER stress and elevates chemo-resistance in lung adenocarcinoma

Published:1 May 2023 DOI: 10.1016/j.drup.2023.100933 PMID: 36821972
Chuandong Zhu , Yufeng Xie , Qiang Li , Zhiwei Zhang , Juan Chen , Kai Zhang , Xuefeng Xia , Danlei Yu , Dongqin Chen , Zhengyuan Yu , Jing Chen

Abstract

Alternative polyadenylation (APA) is a widespread mechanism generating RNA molecules with alternative 3' ends. Herein, we discovered that TargetScan includes a novel XBP1 transcript with a longer 3' untranslated region (UTR) (XBP1-UL) than that included in NCBI. XBP1-UL exhibited a lowered level in blood samples from lung adenocarcinoma (LUAD) patients and in those after DDP treatment. Consistently, XBP1-UL was reduced in A549 cells compared to normal BEAS-2B cells, as well as in DDP-treated/resistant A549 cells relative to controls. Moreover, due to decreased usage of the distal polyadenylation site (PAS) in 3’UTR, XBP1-UL level was lowered in A549 cells and decreased further in DDP-resistant A549 (A549/DDP) cells. Importantly, use of the distal PAS (dPAS) and XBP1-UL level were gradually reduced in A549 cells under increasing concentrations of DDP, which was attributed to DDP-induced endoplasmic reticulum (ER) stress. Furthermore, XBP1 transcripts with shorter 3’UTR (XBP1-US) were more stable and presented stronger potentiation on DDP resistance. The choice of proximal PAS (pPAS) was attributed to CPSF6 elevation, which was caused by BRCA1-distrupted R-loop accumulation in CPSF6 5’end. DDP-induced nuclear LINC00221 also facilitated CPSF6-induced pPAS choice in the pre-XBP1 3’end. Finally, we found that unlike the unspliced XBP1 protein (XBP1-u), the spliced form XBP1-s retarded p53 degradation to facilitate DNA damage repair of LUAD cells. The current study provides new insights into tumor progression and DDP resistance in LUAD, which may contribute to improved LUAD treatment.

Substances (6)

Materials
Procduct Name CAS Molecular Formula Supplier Price
Cisplatin 15663-27-1 Cl2H6N2Pt 919 suppliers $14.00-$7570.00
Cisplatin 15663-27-1 Cl2H6N2Pt 919 suppliers $14.00-$7570.00
Cisplatin 15663-27-1 Cl2H6N2Pt 919 suppliers $14.00-$7570.00
Cisplatin 15663-27-1 Cl2H6N2Pt 919 suppliers $14.00-$7570.00
Cisplatin 15663-27-1 - Inquiry
Cisplatin 15663-27-1 - Inquiry

Similar articles

IF:3.9

Detection of β-lactamase-mediated resistance

Journal of Antimicrobial Chemotherapy D. Livermore,?Derek F. J. Brown,etc Published: 1 July 2001
古交市| 襄城县| 甘孜县| 建瓯市| 柘荣县| 湘阴县| 星子县| 星子县| 汉中市| 汉中市| 阳朔县| 中阳县| 裕民县| 沁阳市| 甘肃省| 阿尔山市| 娄烦县| 剑河县| 古浪县| 上饶县| 台山市| 黑水县| 拉孜县| 安塞县| 苏尼特左旗| 定襄县| 明水县| 常山县| 梅河口市| 阜阳市| 府谷县| 平顺县| 闻喜县| 黑山县| 通州区| 阜新| 华亭县| 崇左市| 南和县| 榆中县| 吴桥县|